[go: up one dir, main page]

Bankey, 1993 - Google Patents

Differential effects of polyunsaturated fatty acids on macrophage cytokine production and signal transduction

Bankey, 1993

Document ID
2605264833812733987
Author
Bankey P
Publication year

External Links

Snippet

Dietary regimens enriched with $\omega $3 PUFA's have anti-inflammatory effects. Mechanisms are unclear; however, suppressed macrophage inflammatory mediator production and reduced responsiveness due to alterations in signal transduction pathways …
Continue reading at search.proquest.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin

Similar Documents

Publication Publication Date Title
Calder Dietary fatty acids and the immune system
Lee et al. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids
Robinson et al. Dietary fish oil reduces progression of established renal disease in (NZB× NZW) F1 mice and delays renal disease in BXSB and MRL/1 strains
Tsuboyama-Kasaoka et al. Up-regulation of liver uncoupling protein-2 mRNA by either fish oil feeding or fibrate administration in mice
Calder Effects of fatty acids and dietary lipids on cells of the immune system
Yamashita et al. Effect of eicosapentaenoic and docosahexaenoic acid on natural killer cell activity in human peripheral blood lymphocytes
US20030032674A1 (en) Use of unsaturated fatty acids to treat severe inflammatory diseases
US20120276212A1 (en) Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities
SK287209B6 (en) Use of a composition consisting of eicosapentaenoic acid and arachidonic acid for the manifacture of a medicament
Mayer et al. Parenteral nutrition with n-3 lipids in sepsis
WO2008058274A2 (en) Use of resolvins and docosatrienes and analogues thereof for the treatment of angiogenesis and ocular neovascularization
Calder Nutritional benefits of omega-3 fatty acids
Holub Dietary fish oils containing eicosapentaenoic acid and the prevention of atherosclerosis and thrombosis
Liao et al. Endotoxin, cytokines, and hyperlipidemia
Kasiske et al. Impact of dietary fatty acid supplementation on renal injury in obese Zucker rats
Bankey Differential effects of polyunsaturated fatty acids on macrophage cytokine production and signal transduction
Morris et al. New perspectives on aspirin and the endogenous control of acute inflammatory resolution
Black et al. Dietary n-3 fatty acids alter murine peritoneal macrophage cytotoxicity
Lai et al. Dietary Platycladus orientalis seed oil suppresses anti-erythrocyte autoantibodies and prolongs survival of NZB mice
Schreiner et al. Diet and kidney disease: the role of dietary fatty acids
Das Essential fatty acids—biochemistry, physiology and clinical significance
Belch The role of eicosanoids in inflammation
CN101010101B (en) Composition comprising protein material and non-oxidizable fatty acid entities
Miller Effects of Omega-3 Fatty Acids on Milk Production Responses and Milk and Plasma Fatty Acids in Dairy Cows
Wallace Dietary fatty acids affect inflammatory mediator production by mirine and human macrophages and lymphocytes